David Cordani - 12 May 2026 Form 4 Insider Report for Cigna Group (CI)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
14 May 2026, 16:47:26 UTC
Prior SEC filing
03 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Tyler Gratton, attorney-in-fact

Key filing fact

David Cordani filed Form 4 for Cigna Group (CI) on 14 May 2026.

Key facts

  • This page summarizes David Cordani's Form 4 filing for Cigna Group (CI).
  • 21 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 14 May 2026, 16:47.

Change

  • Previous filing in this sequence was filed on 03 Mar 2026.
  • Current net transaction value: -$59,114,186.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001318751 Primary reporting owner

Cordani David

Relationship
Chairman & CEO, Director
Address
900 COTTAGE GROVE ROAD, BLOOMFIELD
Signature
Tyler Gratton, attorney-in-fact
Signature date
14 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CI transaction

Common Stock, $.01 Par Value

Options Exercise

Transaction value
Shares
+103,595
Change %
+220%
Price
$149.14*
Shares after
150,696
Date
12 May 2026
Ownership
Direct
Footnotes
F1
CI transaction

Common Stock, $.01 Par Value

Options Exercise

Transaction value
Shares
+85,519
Change %
+57%
Price
$197.35*
Shares after
236,215
Date
12 May 2026
Ownership
Direct
Footnotes
F1
CI transaction

Common Stock, $.01 Par Value

Sale

Transaction value
$1,119,505
Shares
-3,903
Change %
-1.7%
Price
$286.83
Shares after
232,312
Date
12 May 2026
Ownership
Direct
Footnotes
F1, F2
CI transaction

Common Stock, $.01 Par Value

Sale

Transaction value
$4,115,590
Shares
-14,292
Change %
-6.2%
Price
$287.96
Shares after
218,020
Date
12 May 2026
Ownership
Direct
Footnotes
F1, F3
CI transaction

Common Stock, $.01 Par Value

Sale

Transaction value
$3,997,456
Shares
-13,839
Change %
-6.3%
Price
$288.85
Shares after
204,181
Date
12 May 2026
Ownership
Direct
Footnotes
F1, F4
CI transaction

Common Stock, $.01 Par Value

Sale

Transaction value
$11,918,784
Shares
-41,099
Change %
-20%
Price
$290.00
Shares after
163,082
Date
12 May 2026
Ownership
Direct
Footnotes
F1, F5
CI transaction

Common Stock, $.01 Par Value

Sale

Transaction value
$3,996,089
Shares
-13,732
Change %
-8.4%
Price
$291.01
Shares after
149,350
Date
12 May 2026
Ownership
Direct
Footnotes
F1, F6
CI transaction

Common Stock, $.01 Par Value

Sale

Transaction value
$3,595,314
Shares
-12,315
Change %
-8.2%
Price
$291.95
Shares after
137,035
Date
12 May 2026
Ownership
Direct
Footnotes
F1, F7
CI transaction

Common Stock, $.01 Par Value

Sale

Transaction value
$2,302,311
Shares
-7,861
Change %
-5.7%
Price
$292.88
Shares after
129,174
Date
12 May 2026
Ownership
Direct
Footnotes
F1, F8
CI transaction

Common Stock, $.01 Par Value

Sale

Transaction value
$629,574
Shares
-2,142
Change %
-1.7%
Price
$293.92
Shares after
127,032
Date
12 May 2026
Ownership
Direct
Footnotes
F1, F9
CI transaction

Common Stock, $.01 Par Value

Sale

Transaction value
$11,352,888
Shares
-38,487
Change %
-30%
Price
$294.98
Shares after
88,545
Date
12 May 2026
Ownership
Direct
Footnotes
F1, F10
CI transaction

Common Stock, $.01 Par Value

Sale

Transaction value
$10,253,196
Shares
-34,641
Change %
-39%
Price
$295.98
Shares after
53,904
Date
12 May 2026
Ownership
Direct
Footnotes
F1, F11
CI transaction

Common Stock, $.01 Par Value

Sale

Transaction value
$598,718
Shares
-2,017
Change %
-3.7%
Price
$296.84
Shares after
51,887
Date
12 May 2026
Ownership
Direct
Footnotes
F1, F12
CI transaction

Common Stock, $.01 Par Value

Sale

Transaction value
$4,568,735
Shares
-15,319
Change %
-30%
Price
$298.24
Shares after
36,568
Date
12 May 2026
Ownership
Direct
Footnotes
F1, F13
CI transaction

Common Stock, $.01 Par Value

Sale

Transaction value
$666,027
Shares
-2,231
Change %
-6.1%
Price
$298.53
Shares after
34,337
Date
12 May 2026
Ownership
Direct
Footnotes
F1, F14
CI transaction

Common Stock, $.01 Par Value

Options Exercise

Transaction value
Shares
+15,458
Change %
+45%
Price
$149.14*
Shares after
49,795
Date
13 May 2026
Ownership
Direct
Footnotes
F1
CI transaction

Common Stock, $.01 Par Value

Options Exercise

Transaction value
Shares
+7,971
Change %
+16%
Price
$197.35*
Shares after
57,766
Date
13 May 2026
Ownership
Direct
Footnotes
F1
CI holding

Common Stock, $.01 Par Value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
440,798
Date
12 May 2026
Ownership
By GRAT
CI holding

Common Stock, $.01 Par Value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
157,935
Date
12 May 2026
Ownership
By Trust
CI holding

Common Stock, $.01 Par Value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,803
Date
12 May 2026
Ownership
By 401(k)
Footnotes
F15

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CI transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-103,595
Change %
-87%
Price
$0.000000*
Shares after
15,458
Date
12 May 2026
Ownership
Direct
Underlying class
Common Stock, $.01 Par Value
Underlying amount
103,595
Exercise price
$149.14
Footnotes
F1, F16
CI transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-15,458
Change %
-100%
Price
$0.000000*
Shares after
0
Date
13 May 2026
Ownership
Direct
Underlying class
Common Stock, $.01 Par Value
Underlying amount
15,458
Exercise price
$149.14
Footnotes
F1, F16
CI transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-85,519
Change %
-91%
Price
$0.000000*
Shares after
7,971
Date
12 May 2026
Ownership
Direct
Underlying class
Common Stock, $.01 Par Value
Underlying amount
85,519
Exercise price
$197.35
Footnotes
F1, F17
CI transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-7,971
Change %
-100%
Price
$0.000000*
Shares after
0
Date
13 May 2026
Ownership
Direct
Underlying class
Common Stock, $.01 Par Value
Underlying amount
7,971
Exercise price
$197.35
Footnotes
F1, F17
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 17 footnotes

Footnote F1

These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

Footnote F2

Represents the weighted average price of the shares sold. The prices actually received ranged from $286.43 to $287.425 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Footnote F3

Represents the weighted average price of the shares sold. The prices actually received ranged from $287.43 to $288.42 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Footnote F4

Represents the weighted average price of the shares sold. The prices actually received ranged from $288.435 to $289.41 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Footnote F5

Represents the weighted average price of the shares sold. The prices actually received ranged from $289.435 to $290.43 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Footnote F6

Represents the weighted average price of the shares sold. The prices actually received ranged from $290.44 to $291.438 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Footnote F7

Represents the weighted average price of the shares sold. The prices actually received ranged from $291.44 to $292.435 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Footnote F8

Represents the weighted average price of the shares sold. The prices actually received ranged from $292.44 to $293.435 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Footnote F9

Represents the weighted average price of the shares sold. The prices actually received ranged from $293.46 to $294.45 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Footnote F10

Represents the weighted average price of the shares sold. The prices actually received ranged from $294.46 to $295.453 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Footnote F11

Represents the weighted average price of the shares sold. The prices actually received ranged from $295.46 to $296.45 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Footnote F12

Represents the weighted average price of the shares sold. The prices actually received ranged from $296.46 to $297.45 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Footnote F13

Represents the weighted average price of the shares sold. The prices actually received ranged from $297.492 to $298.49 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Footnote F14

Represents the weighted average price of the shares sold. The prices actually received ranged from $298.495 to $298.675 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Footnote F15

Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.

Footnote F16

This option was granted on February 28, 2017. The option vested in three equal annual installments starting on March 1, 2018.

Footnote F17

This option was granted on February 28, 2018. The option vested in three equal annual installments starting on March 1, 2019.

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .